Large-scale testing (Phase 3)Study completedNCT00266552
What this trial is testing
The Safety and Effectiveness of Risperidone Versus Placebo for the Treatment of Conduct Disorder in Children With Mild, Moderate, or Borderline Mental Retardation
Who this might be right for
Conduct DisorderDisruptive Behavior DisorderOppositional Defiant Disorder
Janssen Pharmaceutica N.V., Belgium 118